NPHS1 and liver dysplastic nodule: Previous studies have shown that QDTS reduce urine albumin creatine ratio (UACR) and urine podocin, nephrin and podocalyxin levels in DN patients, suggesting that it can reduce podocyte damage in diabetes [6,8].